Literature DB >> 16983330

Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin.

Isabelle A Leclercq1, Matthieu Vansteenberghe, Valérie B Lebrun, Noémi K VanHul, Jorge Abarca-Quinones, Christine L Sempoux, Chirstian Picard, Peter Stärkel, Yves L Horsmans.   

Abstract

Liver regeneration after partial hepatectomy (PH) is impaired in leptin-deficient ob/ob mice. Here, we tested whether exogenous leptin and/or correction of the obese phenotype (by food restriction or long-term leptin administration) would rescue hepatocyte proliferation and whether the hepatic progenitor cell compartment was activated in leptin-deficient ob/ob livers after PH. Because of the high mortality following 70% PH to ob/ob mice, we performed a less extensive (55%) resection. Compared to lean mice, liver regeneration after 55% PH was deeply impaired and delayed in ob/ob mice. Administration of exogenous leptin to ob/ob mice at doses that restored circulating leptin levels during the surgery and postsurgery period or for 3 weeks prior to the surgical procedure did not rescue defective liver regeneration. Moreover, correction of obesity, metabolic syndrome and hepatic steatosis by prolonged administration of leptin or food restriction (with or without leptin replacement at the time of PH) did not improve liver regeneration in ob/ob mice. The hepatic progenitor cell compartment was increased in ob/ob mice. However, after PH, the number of progenitor cells decreased and signs of proliferation were absent from this cell compartment. In this study, we have conclusively shown that neither leptin replacement nor amelioration of the metabolic syndrome, obese phenotype and hepatic steatosis, with or without restitution of normal circulating levels of leptin, was able to restore replicative competence to ob/ob livers after PH. Thus, leptin does not directly signal to liver cells to promote hepatocyte proliferation, and the obese phenotype is not solely responsible for impaired regeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983330     DOI: 10.1038/labinvest.3700474

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.

Authors:  Hideyuki Ogiso; Hiroyasu Ito; Ayumu Kanbe; Tatsuya Ando; Akira Hara; Masahito Shimizu; Hisataka Moriwaki; Mitsuru Seishima
Journal:  Dig Dis Sci       Date:  2017-06-21       Impact factor: 3.199

Review 2.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

3.  Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.

Authors:  Géraldine Gentric; Vanessa Maillet; Valérie Paradis; Dominique Couton; Antoine L'Hermitte; Ganna Panasyuk; Bernard Fromenty; Séverine Celton-Morizur; Chantal Desdouets
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

4.  Analysis of the role of hepatic PPARγ expression during mouse liver regeneration.

Authors:  Vered Gazit; Jiansheng Huang; Alexander Weymann; David A Rudnick
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

5.  Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice.

Authors:  Vered Gazit; Alexander Weymann; Eric Hartman; Brian N Finck; Paul W Hruz; Anatoly Tzekov; David A Rudnick
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

6.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.

Authors:  Elizabeth P Newberry; Susan M Kennedy; Yan Xie; Jianyang Luo; Susan E Stanley; Clay F Semenkovich; Roseanne M Crooke; Mark J Graham; Nicholas O Davidson
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

8.  Pioglitazone: more than just an insulin sensitizer.

Authors:  Mark J Czaja
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

9.  A20 modulates lipid metabolism and energy production to promote liver regeneration.

Authors:  Scott M Damrauer; Peter Studer; Cleide G da Silva; Christopher R Longo; Haley E Ramsey; Eva Csizmadia; Gautam V Shrikhande; Salvatore T Scali; Towia A Libermann; Manoj K Bhasin; Christiane Ferran
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

10.  Functional Relationships between Lipid Metabolism and Liver Regeneration.

Authors:  David A Rudnick; Nicholas O Davidson
Journal:  Int J Hepatol       Date:  2012-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.